{
  "id": "fibrotic_nash_index",
  "title": "Fibrotic NASH Index (FNI)",
  "description": "Screens for fibrotic NASH in individuals at high risk for NAFLD. Uses AST, HbA1c, and HDL cholesterol to calculate probability of fibrotic nonalcoholic steatohepatitis.",
  "category": "gastroenterology",
  "version": "2023",
  "parameters": [
    {
      "name": "ast",
      "type": "float",
      "required": true,
      "description": "Aspartate aminotransferase (AST) level",
      "validation": {
        "min": 5,
        "max": 1000
      },
      "unit": "U/L"
    },
    {
      "name": "hba1c",
      "type": "float",
      "required": true,
      "description": "Hemoglobin A1c (glycated hemoglobin)",
      "validation": {
        "min": 3,
        "max": 20
      },
      "unit": "%"
    },
    {
      "name": "hdl",
      "type": "float",
      "required": true,
      "description": "HDL cholesterol level",
      "validation": {
        "min": 10,
        "max": 200
      },
      "unit": "mg/dL"
    }
  ],
  "result": {
    "name": "fni_score",
    "type": "float",
    "unit": "probability",
    "description": "FNI score representing probability of fibrotic NASH (0-1)"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 0.10,
        "stage": "Low Risk",
        "description": "Fibrotic NASH ruled out",
        "interpretation": "Fibrotic NASH can be confidently ruled out. Negative predictive value 0.93. No immediate need for liver specialist referral. Continue routine monitoring in primary care."
      },
      {
        "min": 0.10,
        "max": 0.33,
        "stage": "Indeterminate Risk",
        "description": "Further evaluation needed",
        "interpretation": "Cannot rule in or rule out fibrotic NASH. Consider additional non-invasive tests (e.g., FIB-4, NAFLD fibrosis score). May warrant referral to hepatology for further evaluation."
      },
      {
        "min": 0.33,
        "max": 1.0,
        "stage": "High Risk",
        "description": "Likely fibrotic NASH",
        "interpretation": "High probability of fibrotic NASH. Specificity ≥0.90, positive predictive value 0.57. Refer to liver specialist for further investigation. Consider liver biopsy or advanced imaging."
      }
    ]
  },
  "references": [
    "Tavaglione F, Jamialahmadi O, De Vincentis A, Qadri S, Mowlaei ME, Mancina RM, et al. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1523-1532.e1. doi: 10.1016/j.cgh.2022.03.044."
  ],
  "formula": "FNI = e^x / (1 + e^x), where x = -10.33 + 2.54 × ln(AST) + 3.86 × ln(HbA1c) - 1.66 × ln(HDL)",
  "notes": [
    "Designed for primary care and endocrinology/diabetology settings",
    "Performance maintained in patients with diabetes (AUROC 0.78-0.95)",
    "Should NOT be used in patients with alcohol use disorder or known chronic liver disease",
    "Best for ruling out rather than diagnosing fibrotic NASH",
    "FNI > 0.1 indicates 4-fold increased risk of severe liver disease vs general population"
  ]
}